3rd Quarter - Report

COREWELL HEALTH for COREWELL HEALTH

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health system financial challenges.

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare - Recalculating of MA Star Ratings. Childhood Vaccine Policy. No Surprises Act.

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: HOUSE OF REPRESENTATIVES

Pharmacy PHA

PBM Reform/Oversight. Transparency and high costs associated with prescription drugs. 340B - Reforms to protect the integrity of the program.

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE

Labor Issues/Antitrust/Workplace LBR

Workforce Shortage within Healthcare Industry.

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Immigration IMM

Visa Fees - Health care exemption.

LobbyistCovered position, as disclosed
KRISTINA KO Chief Government Affairs Officer
PHILIP D YEITER Senior Director, Government Relations

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.